By developing apoptosis-resistant SW839 and OS-RC-2 RCC cell lines through continuous exposure to the selective Bcl-2 inhibitor ABT-199, we observed that RNF25 was overexpressed in these resistant cells. Here, BCL2 is linked to renal cell carcinoma.